To get coverage, you usually need a Body Mass Index (BMI) of 30 or higher
Food and Drug Administration (FDA) that was discovered to be a missing link for weight loss by accident
Retatrutide is an investigational triple agonist targeting GLP-1, GIP, and glucagon receptors, currently unlicensed by the MHRA or EMA and still being evaluated in Phase 2 and Phase 3 clinical trials
Right now, the Food and Drug Administration's guideline for semaglutide is to wait two months before trying to conceive, while the recommendation for tirzepatide is to stop taking it as soon as you learn youre pregnant
It analyzes pathway-level variants (GLP1R (rs6923761), GIPR, FTO, and MC4R) that relate to the biology involved, offering context for a conversation with your provider rather than a prediction